U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
APRUTUMAB
INN   WHO-DD  
INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(FIBROBLAST GROWTH FACTOR RECEPTOR TYPE 2) (SYNTHETIC HUMAN MONOCLONAL BAY 1179470 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN MONOCLONAL BAY 1179470 LIGHT CHAIN, DIMER
Common Name English
BAY-1179470
Code English
Aprutumab [WHO-DD]
Common Name English
aprutumab [INN]
Common Name English
AGC-2500
Code English
Code System Code Type Description
CAS
1634620-63-5
Created by admin on Sat Dec 16 12:23:08 GMT 2023 , Edited by admin on Sat Dec 16 12:23:08 GMT 2023
PRIMARY
INN
10382
Created by admin on Sat Dec 16 12:23:08 GMT 2023 , Edited by admin on Sat Dec 16 12:23:08 GMT 2023
PRIMARY
NCI_THESAURUS
C107683
Created by admin on Sat Dec 16 12:23:08 GMT 2023 , Edited by admin on Sat Dec 16 12:23:08 GMT 2023
PRIMARY
FDA UNII
GK8781218Z
Created by admin on Sat Dec 16 12:23:08 GMT 2023 , Edited by admin on Sat Dec 16 12:23:08 GMT 2023
PRIMARY
ACTIVE MOIETY
APRUTUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966